{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:44:23Z","timestamp":1791074663294,"version":"4.1.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Netherlands Heart Foundation","award":["NHS2007B77"],"award-info":[{"award-number":["NHS2007B77"]}]},{"name":"Netherlands Heart Foundation","award":["NHS2003T302"],"award-info":[{"award-number":["NHS2003T302"]}]},{"name":"Center of Translational Molecular Medicine (CTMM)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.yjmcc.2011.04.017","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T04:04:31Z","timestamp":1305000271000},"page":"156-167","source":"Crossref","is-referenced-by-count":19,"title":["Tapping the brake on cardiac growth-endogenous repressors of hypertrophic signaling-"],"prefix":"10.1016","volume":"51","author":[{"given":"Joost J.","family":"Leenders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigal M.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther E.","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2011.04.017_bb0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular mechanisms of myocardial remodeling","volume":"79","author":"Swynghedauw","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.physiol.62.1.289","article-title":"Genetic dissection of cardiac growth control pathways","volume":"62","author":"MacLellan","year":"2000","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cardiores.2004.03.015","article-title":"Negative regulators of cardiac hypertrophy","volume":"63","author":"Hardt","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Care","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0030","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of stress-dependent cardiac growth and gene expression by a microRNA","volume":"316","author":"van Rooij","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrcardio.2009.56","article-title":"MicroRNAs and cardiac pathology","volume":"6","author":"Latronico","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0045","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.109.889048","article-title":"MicroRNAs add a new dimension to cardiovascular disease","volume":"121","author":"Small","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0050","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0055","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1242\/jcs.03266","article-title":"Diverse physiological functions for dual-specificity MAP kinase phosphatases","volume":"119","author":"Dickinson","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0060","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0065","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.CIR.0000138190.50127.6A","article-title":"Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload","volume":"110","author":"Harris","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0070","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1172\/JCI200420317","article-title":"Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis","volume":"114","author":"Yamaguchi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0075","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"Purcell","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0080","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/emboj\/cdg474","article-title":"c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin\u2013NFAT signaling","volume":"22","author":"Liang","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0085","doi-asserted-by":"crossref","first-page":"27449","DOI":"10.1074\/jbc.M110.107292","article-title":"Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity","volume":"285","author":"Leenders","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.139.1.115","article-title":"A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression","volume":"139","author":"Zechner","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/75037","article-title":"TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice","volume":"6","author":"Zhang","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0100","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/MCB.18.6.3518","article-title":"Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy","volume":"18","author":"Nemoto","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0105","first-page":"H1269","article-title":"Swimming stress in DN 14-3-3 mice triggers maladaptive cardiac remodeling: role of p38 MAPK","volume":"292","author":"Watanabe","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0110","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.211086598","article-title":"The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy","volume":"98","author":"Liao","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0115","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1172\/JCI16290","article-title":"The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis","volume":"111","author":"Zhang","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0120","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1128\/MCB.24.24.10611-10620.2004","article-title":"p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload","volume":"24","author":"Nishida","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.yjmcc.2008.01.011","article-title":"Small GTP-binding proteins and their regulators in cardiac hypertrophy","volume":"44","author":"Lezoualc'h","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0130","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1172\/JCI37694","article-title":"Cdc42 is an antihypertrophic molecular switch in the mouse heart","volume":"119","author":"Maillet","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/CIRCRESAHA.108.188292","article-title":"Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth","volume":"104","author":"Liu","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0092-8674(00)80351-7","article-title":"Activation mechanism of the MAP kinase ERK2 by dual phosphorylation","volume":"90","author":"Canagarajah","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0145","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1074\/jbc.270.13.7420","article-title":"Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine","volume":"270","author":"Raingeaud","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.RES.88.1.88","article-title":"The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo","volume":"88","author":"Bueno","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0155","doi-asserted-by":"crossref","first-page":"15913","DOI":"10.1074\/jbc.M100452200","article-title":"Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes","volume":"276","author":"Lim","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0160","doi-asserted-by":"crossref","first-page":"54905","DOI":"10.1074\/jbc.M407383200","article-title":"Mitogen-activated protein kinases and mitogen-activated protein kinase phosphatases mediate the inhibitory effects of all-trans retinoic acid on the hypertrophic growth of cardiomyocytes","volume":"279","author":"Palm-Leis","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0165","doi-asserted-by":"crossref","first-page":"14730","DOI":"10.1073\/pnas.94.26.14730","article-title":"Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A","volume":"94","author":"Oliver","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbrc.2004.07.119","article-title":"Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1","volume":"322","author":"Hayashi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0175","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.1073\/pnas.260501097","article-title":"Calsarcins, a novel family of sarcomeric calcineurin-binding proteins","volume":"97","author":"Frey","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0180","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/nm1132","article-title":"Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress","volume":"10","author":"Frey","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0185","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/CIRCULATIONAHA.107.711317","article-title":"Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy","volume":"116","author":"Frank","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0190","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI24178","article-title":"Protein kinase cascades in the regulation of cardiac hypertrophy","volume":"115","author":"Dorn","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/cvr\/cvp001","article-title":"Protein kinase C in heart failure: a therapeutic target?","volume":"82","author":"Palaniyandi","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0200","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCRESAHA.108.173807","article-title":"PICOT: a multidomain scaffolding inhibitor of hypertrophic signal transduction","volume":"102","author":"Samarel","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/01.RES.0000234780.06115.2c","article-title":"PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility","volume":"99","author":"Jeong","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0210","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.yjmcc.2008.09.124","article-title":"PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility","volume":"45","author":"Cha","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0215","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCRESAHA.107.165985","article-title":"PICOT attenuates cardiac hypertrophy by disrupting calcineurin\u2013NFAT signaling","volume":"102","author":"Jeong","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0220","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1073\/pnas.0405488102","article-title":"Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein\u2013calcineurin signaling at the sarcomeric Z-disc","volume":"102","author":"Heineke","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1172\/JCI33255","article-title":"The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice","volume":"118","author":"Kim","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1050-1738(00)00039-6","article-title":"Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology","volume":"10","author":"Han","year":"2000","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0235","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI8551","article-title":"CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo","volume":"105","author":"Passier","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0240","doi-asserted-by":"crossref","first-page":"48617","DOI":"10.1074\/jbc.M206532200","article-title":"Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy","volume":"277","author":"van Rooij","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0245","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1161\/CIRCULATIONAHA.105.533778","article-title":"Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart","volume":"112","author":"Parlakian","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0250","doi-asserted-by":"crossref","first-page":"30245","DOI":"10.1074\/jbc.M102174200","article-title":"The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo","volume":"276","author":"Liang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2004.09.037","article-title":"Biological control through regulated transcriptional coactivators","volume":"119","author":"Spiegelman","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000197782.21444.8f","article-title":"Control of cardiac growth by histone acetylation\/deacetylation","volume":"98","author":"Backs","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0959-437X(00)00224-0","article-title":"Control of muscle development by dueling HATs and HDACs","volume":"11","author":"McKinsey","year":"2001","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0275","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1073\/pnas.080064097","article-title":"Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases","volume":"97","author":"Lu","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0280","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/MCB.17.2.1010","article-title":"Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C","volume":"17","author":"Sartorelli","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0285","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"Zhang","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0290","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cell.2008.04.041","article-title":"A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy","volume":"133","author":"Ago","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0295","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/ars.2007.1529","article-title":"Thioredoxin1 as a negative regulator of cardiac hypertrophy","volume":"9","author":"Ago","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0300","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","article-title":"Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development","volume":"24","author":"Chang","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0305","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cell.2006.02.048","article-title":"The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases","volume":"125","author":"Song","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0310","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1128\/MCB.25.22.9936-9948.2005","article-title":"The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment","volume":"25","author":"Dai","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0315","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/14728220902939161","article-title":"Targeting histone deacetylases for heart failure","volume":"13","author":"Bush","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0320","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.RES.0000218781.23144.3e","article-title":"Myocardin induces cardiomyocyte hypertrophy","volume":"98","author":"Xing","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCRESAHA.109.207084","article-title":"Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor","volume":"106","author":"van Rooij","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0330","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0335","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1552","article-title":"Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity","volume":"13","author":"Trivedi","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0340","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gad.1563807","article-title":"Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility","volume":"21","author":"Montgomery","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0345","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","article-title":"Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice","volume":"118","author":"Montgomery","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0350","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1242\/jcs.081067","article-title":"Sirtuins at a glance","volume":"124","author":"Nakagawa","year":"2011","journal-title":"J Cell Sci"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0355","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature08778","article-title":"SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation","volume":"464","author":"Hirschey","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0360","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygeno.2004.11.003","article-title":"A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages","volume":"85","author":"Bellizzi","year":"2005","journal-title":"Genomics"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0365","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","article-title":"Sirt1 regulates aging and resistance to oxidative stress in the heart","volume":"100","author":"Alcendor","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0370","first-page":"2758","article-title":"Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice","volume":"119","author":"Sundaresan","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0375","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI200524408","article-title":"Oxygen, oxidative stress, hypoxia, and heart failure","volume":"115","author":"Giordano","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0380","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1089\/152308603770380034","article-title":"Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes","volume":"5","author":"Sabri","year":"2003","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0385","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/hrt.2005.068270","article-title":"Oxidative stress and redox signalling in cardiac hypertrophy and heart failure","volume":"93","author":"Seddon","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0390","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/152308603770380098","article-title":"Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases","volume":"5","author":"Takano","year":"2003","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0395","first-page":"H2040","article-title":"Oxygen sensing and redox signaling: the role of thioredoxin in embryonic development and cardiac diseases","volume":"292","author":"Kobayashi-Miura","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0400","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI200317700","article-title":"Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy","volume":"112","author":"Yamamoto","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0405","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.biocel.2007.07.018","article-title":"Kruppel-like transcription factors: a functional family","volume":"40","author":"Pearson","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0410","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1128\/MCB.20.19.7319-7331.2000","article-title":"Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Kruppel-like factor, a novel zinc finger repressor","volume":"20","author":"Uchida","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0415","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1073\/pnas.0701981104","article-title":"Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy","volume":"104","author":"Fisch","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0420","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000502","article-title":"Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation","volume":"2","author":"Haldar","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0425","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05602","article-title":"p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload","volume":"446","author":"Sano","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0430","doi-asserted-by":"crossref","first-page":"34322","DOI":"10.1074\/jbc.M201304200","article-title":"The Kruppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4","volume":"277","author":"Gray","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0435","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.yjmcc.2010.04.008","article-title":"Kruppel-like factor 4 regulates pressure-induced cardiac hypertrophy","volume":"49","author":"Liao","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0440","doi-asserted-by":"crossref","first-page":"21175","DOI":"10.1074\/jbc.M110.112482","article-title":"Smooth and cardiac muscle-selective knockout of Kruppel-like factor 4 causes postnatal death and growth retardation","volume":"285","author":"Yoshida","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0445","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.yjmcc.2009.08.022","article-title":"Kruppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy","volume":"47","author":"Kee","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0450","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.RES.0000338570.27156.84","article-title":"Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy","volume":"103","author":"Kee","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0455","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1093\/nar\/23.23.4907","article-title":"Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts","volume":"23","author":"Subramaniam","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0460","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcb.21049","article-title":"TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: discovery and characterization of a novel signaling pathway","volume":"100","author":"Rajamannan","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0465","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/jcb.21425","article-title":"Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors","volume":"103","author":"Hawse","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0470","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/15275","article-title":"Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis","volume":"5","author":"Heaney","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0475","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCRESAHA.110.235309","article-title":"Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart","volume":"108","author":"Sachan","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0480","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/gt.2010.141","article-title":"microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors","volume":"18","author":"Geisler","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0485","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/CIRCULATIONAHA.108.783852","article-title":"Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy","volume":"119","author":"Suckau","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0490","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1073\/pnas.0813207106","article-title":"A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection","volume":"106","author":"Yang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0495","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gt.2010.105","article-title":"Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution","volume":"18","author":"Prasad","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0500","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/CIRCULATIONAHA.109.863266","article-title":"Absence of thrombospondin-2 causes age-related dilated cardiomyopathy","volume":"120","author":"Swinnen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0505","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial","volume":"15","author":"Jaski","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0510","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCRESAHA.109.209338","article-title":"Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors","volume":"106","author":"Bush","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0515","article-title":"Isoform-selective HDAC inhibitors: closing in on translational medicine for the heart","author":"McKinsey","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0520","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14740338.7.1.53","article-title":"Histone deacetylase inhibition in the treatment of heart disease","volume":"7","author":"Berry","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0530","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","article-title":"Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer","volume":"23","author":"Kelly","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0535","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/hc1002.105225","article-title":"Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo","volume":"105","author":"Asakawa","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0540","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm891","article-title":"Deletion of cytosolic phospholipase A2 promotes striated muscle growth","volume":"9","author":"Haq","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0545","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI41407","article-title":"GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice","volume":"120","author":"Zhou","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0550","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","article-title":"Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo","volume":"99","author":"Antos","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0555","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI36245","article-title":"Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation","volume":"118","author":"Kerkela","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0560","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.yjmcc.2009.12.019","article-title":"KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling","volume":"48","author":"Jin","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0565","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0092-8674(01)00588-8","article-title":"A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia","volume":"107","author":"Kuo","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0570","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","article-title":"Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3\u2013LKB1\u2013AMP-activated kinase pathway","volume":"285","author":"Pillai","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0575","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.yjmcc.2010.02.009","article-title":"Post-translational regulation of calsarcin-1 during pressure overload-induced cardiac hypertrophy","volume":"48","author":"Paulsson","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0580","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1073\/pnas.041614798","article-title":"Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo","volume":"98","author":"Rothermel","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0585","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/01.RES.0000118597.54416.00","article-title":"MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction","volume":"94","author":"van Rooij","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0590","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1073\/pnas.0237225100","article-title":"Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy","volume":"100","author":"Vega","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0595","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/HYPERTENSIONAHA.108.120816","article-title":"Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling","volume":"53","author":"Cai","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0600","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0002-9440(10)61168-6","article-title":"Caveolin-1\/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype","volume":"160","author":"Park","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0605","doi-asserted-by":"crossref","first-page":"38988","DOI":"10.1074\/jbc.M205511200","article-title":"Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42\/44 MAPK cascade","volume":"277","author":"Woodman","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0610","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.CIR.0000086978.95976.41","article-title":"A20 is dynamically regulated in the heart and inhibits the hypertrophic response","volume":"108","author":"Cook","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0615","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/HYPERTENSIONAHA.110.149963","article-title":"Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-{beta}-activated kinase 1-dependent signaling","volume":"56","author":"Huang","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0620","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cellsig.2010.03.015","article-title":"RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy","volume":"22","author":"Nunn","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0625","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1172\/JCI6713","article-title":"RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload","volume":"104","author":"Rogers","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0630","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/CIRCULATIONAHA.107.732990","article-title":"Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart","volume":"117","author":"Tokudome","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0635","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI13939","article-title":"Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways","volume":"108","author":"Yasukawa","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0640","doi-asserted-by":"crossref","first-page":"31915","DOI":"10.1074\/jbc.272.50.31915","article-title":"S100beta inhibits alpha1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes","volume":"272","author":"Tsoporis","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0645","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1172\/JCI3077","article-title":"Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice","volume":"102","author":"Tsoporis","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0650","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/hc4001.097183","article-title":"Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy","volume":"104","author":"Tian","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0655","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.108.114702","article-title":"AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice","volume":"52","author":"Zhang","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0660","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1073\/pnas.162100799","article-title":"Inhibition of calcineurin\u2013NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes","volume":"99","author":"Fiedler","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0665","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0670","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/HJH.0b013e3282f6a179","article-title":"c-Flip overexpression reduces cardiac hypertrophy in response to pressure overload","volume":"26","author":"Giampietri","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0675","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/MCB.00882-06","article-title":"Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2","volume":"27","author":"Gregoire","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0680","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1272","article-title":"The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy","volume":"11","author":"Buitrago","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0685","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/cvr\/cvp180","article-title":"Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kappaB signalling","volume":"84","author":"Wu","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"Pt 2","key":"10.1016\/j.yjmcc.2011.04.017_bb0690","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj3230313","article-title":"Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes","volume":"323","author":"Fuller","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0695","doi-asserted-by":"crossref","first-page":"17320","DOI":"10.1074\/jbc.M109.006759","article-title":"DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy","volume":"284","author":"Kuhn","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0700","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/ncb2126","article-title":"MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin\/NFAT signalling","volume":"12","author":"da Costa Martins","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0705","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.RES.0000012922.40318.05","article-title":"Identification of IEX-1 as a biomechanically controlled nuclear factor-kappaB target gene that inhibits cardiomyocyte hypertrophy","volume":"90","author":"De Keulenaer","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0710","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/HYPERTENSIONAHA.107.102566","article-title":"Myocardial protection against pressure overload in mice lacking Bach1, a transcriptional repressor of heme oxygenase-1","volume":"51","author":"Mito","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0715","first-page":"H2082","article-title":"The bHLH transcription factor CHF1\/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload","volume":"298","author":"Liu","year":"2010","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0720","doi-asserted-by":"crossref","first-page":"16197","DOI":"10.1073\/pnas.252648999","article-title":"Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1\/Hey2","volume":"99","author":"Sakata","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2011.04.017_bb0725","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/omi.2009.0086","article-title":"CHF1\/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways","volume":"13","author":"Yu","year":"2009","journal-title":"Omics"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811001775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811001775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T17:19:14Z","timestamp":1560187154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282811001775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":145,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0022282811001775"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2011.04.017","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}